5 Key Takeaways
-
1
Innovations in interventional glaucoma management allow for earlier treatment and reduced need for intensive interventions.
-
2
Genetic testing for glaucoma aids in risk assessment and encourages patient adherence to follow-up appointments.
-
3
The LiGHT Trial demonstrates that selective laser trabeculoplasty effectively controls disease and reduces reliance on medication.
-
4
Minimally invasive glaucoma surgery (MIGS) offers significant IOP reductions with minimal disruption and rapid recovery.
-
5
Nutraceuticals and dietary changes can support glaucoma management, contributing to optic nerve health and disease progression prevention.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.